Establishment Labs Holdings (ESTA) Shares Outstanding (Diluted Average) (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Shares Outstanding (Diluted Average) of $29.9 million in Q1 2026, up 1.1% quarter-over-quarter from $29.6 million in Q4 2025, and up 1.6% on a YoY basis from $29.5 million in Q1 2025.
Establishment Labs Holdings (ESTA) Shares Outstanding (Diluted Average) (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $29.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 1.6% year-over-year to $29.9 million; the TTM figure through Mar 2026 stood at $29.9 million (up 1.6% YoY), while the FY2025 annual figure was $29.6 million, up 5.18% from the prior year.
- Shares Outstanding (Diluted Average) was $29.9 million for Q1 2026 at Establishment Labs Holdings, up from $29.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $29.9 million in Q1 2026 to a low of $24.3 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $27.0 million across 5 years, with a median of $27.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) increased 1.51% in 2023, then grew 12.6% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $24.5 million in 2022, then increased by 4.67% to $25.6 million in 2023, then grew by 10.01% to $28.2 million in 2024, then increased by 5.18% to $29.6 million in 2025, then rose by 1.1% to $29.9 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $29.9 million (Q1 2026), $29.6 million (Q4 2025), and $29.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | 29.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.95 Mn |
| Dec 31, 2025 | 29.62 Mn |
| Sep 30, 2025 | 29.62 Mn |
| Jun 30, 2025 | 28.88 Mn |
| Mar 31, 2025 | 29.48 Mn |
| Dec 31, 2024 | 28.16 Mn |
| Sep 30, 2024 | 28.25 Mn |
| Jun 30, 2024 | 27.68 Mn |
| Mar 31, 2024 | 27.79 Mn |
| Dec 31, 2023 | 25.60 Mn |
| Sep 30, 2023 | 26.03 Mn |
| Jun 30, 2023 | 25.14 Mn |
| Mar 31, 2023 | 24.68 Mn |
| Dec 31, 2022 | 24.46 Mn |
| Sep 30, 2022 | 24.41 Mn |
| Jun 30, 2022 | 24.35 Mn |
| Mar 31, 2022 | 24.31 Mn |
| Dec 31, 2021 | 23.97 Mn |
| Sep 30, 2021 | 23.89 Mn |
| Jun 30, 2021 | 23.95 Mn |